| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Antitumor effects of BI-D1870 on human oral squamous cell carcinoma
|
Chiu, Chang-Fang
|
|
2013
|
73 |
2 |
p. 237-247
|
artikel
|
| 2 |
A phase I trial of combination therapy using gemcitabine and S-1 concurrent with full-dose radiation for resectable pancreatic cancer
|
Eguchi, Hidetoshi
|
|
2013
|
73 |
2 |
p. 309-315
|
artikel
|
| 3 |
A phase I trial of flavopiridol in relapsed multiple myeloma
|
Hofmeister, Craig C.
|
|
2013
|
73 |
2 |
p. 249-257
|
artikel
|
| 4 |
A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors
|
Tolcher, Anthony W.
|
|
2013
|
73 |
2 |
p. 363-371
|
artikel
|
| 5 |
Assessing physico-chemical compatibility of concomitantly diluted antiemetics including palonosetron-HCl and fosaprepitant dimeglumine
|
Lipp, Hans-Peter
|
|
2013
|
73 |
2 |
p. 435-436
|
artikel
|
| 6 |
Cabozantinib: a novel agent with a dual mechanism of action for castration-resistant prostate carcinoma
|
Pinto, Álvaro
|
|
2013
|
73 |
2 |
p. 219-222
|
artikel
|
| 7 |
CA19-9 level as a prognostic and predictive factor of bevacizumab efficacy in metastatic colorectal cancer patients undergoing oxaliplatin-based chemotherapy
|
Narita, Yukiya
|
|
2013
|
73 |
2 |
p. 409-416
|
artikel
|
| 8 |
Changes of cytokines in patients with liver cirrhosis and advanced hepatocellular carcinoma treated by sorafenib
|
Nagai, Hidenari
|
|
2013
|
73 |
2 |
p. 223-229
|
artikel
|
| 9 |
First-in-human phase II trial of the botanical formulation PHY906 with capecitabine as second-line therapy in patients with advanced pancreatic cancer
|
Saif, Muhammad Wasif
|
|
2013
|
73 |
2 |
p. 373-380
|
artikel
|
| 10 |
Fractionation of daily dose increases the predicted risk of severe sorafenib-induced hand–foot syndrome (HFS)
|
Hénin, Emilie
|
|
2013
|
73 |
2 |
p. 287-297
|
artikel
|
| 11 |
Increased sensitivity to glucose starvation correlates with downregulation of glycogen phosphorylase isoform PYGB in tumor cell lines resistant to 2-deoxy-d-glucose
|
Philips, Katherine B.
|
|
2013
|
73 |
2 |
p. 349-361
|
artikel
|
| 12 |
Induction of DNA damage and p21-dependent senescence by Riccardin D is a novel mechanism contributing to its growth suppression in prostate cancer cells in vitro and in vivo
|
Hu, Zhongyi
|
|
2013
|
73 |
2 |
p. 397-407
|
artikel
|
| 13 |
Mechanisms affecting neutrophil migration capacity in breast cancer patients before and after chemotherapy
|
Mendonça, Maria Angélica Oliveira
|
|
2013
|
73 |
2 |
p. 317-324
|
artikel
|
| 14 |
Pharmacokinetics of panitumumab in a patient with liver dysfunction: a case report
|
Krens, L. L.
|
|
2013
|
73 |
2 |
p. 429-433
|
artikel
|
| 15 |
Phase I dose-escalation study of oral vinflunine in combination with erlotinib in pre-treated and unselected EGFR patients with locally advanced or metastatic non-small-cell lung cancer
|
Krzakowski, M.
|
|
2013
|
73 |
2 |
p. 231-236
|
artikel
|
| 16 |
Pilot trial of EZN-2968, an antisense oligonucleotide inhibitor of hypoxia-inducible factor-1 alpha (HIF-1α), in patients with refractory solid tumors
|
Jeong, Woondong
|
|
2013
|
73 |
2 |
p. 343-348
|
artikel
|
| 17 |
p75 neurotrophin receptor and fenretinide-induced signaling in neuroblastoma
|
Ganeshan, Veena R.
|
|
2013
|
73 |
2 |
p. 271-279
|
artikel
|
| 18 |
Predictive and prognostic value of early response assessment using 18FDG-PET in advanced non-small cell lung cancer patients treated with erlotinib
|
Tiseo, Marcello
|
|
2013
|
73 |
2 |
p. 299-307
|
artikel
|
| 19 |
Preoperative S-1 and docetaxel combination chemotherapy in patients with locally advanced gastric cancer
|
Kosaka, Takashi
|
|
2013
|
73 |
2 |
p. 281-285
|
artikel
|
| 20 |
Prognostic role of microRNA polymorphisms in patients with advanced esophageal squamous cell carcinoma receiving platinum-based chemotherapy
|
Wu, Chaohui
|
|
2013
|
73 |
2 |
p. 335-341
|
artikel
|
| 21 |
Randomized controlled study of gemcitabine plus S-1 combination chemotherapy versus gemcitabine for unresectable pancreatic cancer
|
Sudo, Kentaro
|
|
2013
|
73 |
2 |
p. 389-396
|
artikel
|
| 22 |
Reply to: assessing physico-chemical compatibility of concomitantly diluted antiemetics including palonosetron-HCl and fosaprepitant dimeglumine
|
Duersch, Brett
|
|
2014
|
73 |
2 |
p. 437
|
artikel
|
| 23 |
Role of sunitinib and SU12662 on dermatological toxicities in metastatic renal cell carcinoma patients: in vitro, in vivo, and outcomes investigation
|
Teo, Yi Ling
|
|
2013
|
73 |
2 |
p. 381-388
|
artikel
|
| 24 |
Targeting cisplatin-resistant human tumor cells with metabolic inhibitors
|
Sullivan, Elizabeth J.
|
|
2013
|
73 |
2 |
p. 417-427
|
artikel
|
| 25 |
TS mRNA levels can predict pemetrexed and raltitrexed sensitivity in colorectal cancer
|
Zhang, Qun
|
|
2013
|
73 |
2 |
p. 325-333
|
artikel
|
| 26 |
Vascular-targeted agents for the treatment of angiosarcoma
|
Young, R. J.
|
|
2013
|
73 |
2 |
p. 259-270
|
artikel
|
Tijdschrift beschrijving